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Retinoic acid (RA), the active derivative of vitamin A, has been
implicated in various steps of cardiovascular development. The
retinaldehyde dehydrogenase 2 (RALDH2) enzyme catalyzes the
second oxidative step in RA biosynthesis and its loss of function
creates a severe embryonic RA deficiency. Raldh2/ knockout
embryos fail to undergo heart looping and have impaired atrial and
sinus venosus development. To understand the mechanism(s) pro-
ducing these changes, we examined the contribution of the second
heart field (SHF) to pharyngeal mesoderm, atria, and outflow tract
in Raldh2/ embryos. RA deficiency alters SHF gene expression in
two ways. First, Raldh2/ embryos exhibited a posterior expan-
sion of anterior markers of the SHF, including Tbx1, Fgf8, and the
Mlc1v-nlacZ-24/Fgf10 reporter transgene as well as of Islet1. This
occurred at early somite stages, when cardiac defects became
irreversible in an avian vitamin A-deficiency model, indicating that
endogenous RA is required to restrict the SHF posteriorly. Explant
studies showed that this expanded progenitor population cannot
differentiate properly. Second, RA up-regulated cardiac Bmp ex-
pression levels at the looping stage. The contribution of the SHF to
both inflow and outflow poles was perturbed under RA deficiency,
creating a disorganization of the heart tube. We also investigated
genetic cross-talk between Nkx2.5 and RA signaling by generating
double mutant mice. Strikingly, Nkx2.5 deficiency was able to
rescue molecular defects in the posterior region of the Raldh2/
mutant heart, in a gene dosage-dependent manner.
retinoids  retinaldehyde dehydrogenase 2  heart development 
Nkx2.5  FGF8
Cardiogenesis requires specification, proliferation, differen-tiation, and migration of cell populations from diverse sites.
Retinoic acid (RA), the active derivative of vitamin A, by acting
as a diffusible activator of nuclear receptors, critically regulates
a variety of steps and stages of cardiovascular development (1).
Various animal models have been used to examine RA-
dependent heart development, including knockout mice defi-
cient in retinaldehyde dehydrogenase 2 (RALDH2), which
catalyzes the second oxidative step in RA biosynthesis.
Raldh2/mutants exhibit a severe deficiency in RA production,
defects of heart looping (2, 3), reduced posterior chamber (atria
and sinus venosus) outgrowth, and defective ventricular trabe-
culation (4).
RA has been implicated in the early specification and pat-
terning of the cardiac field in zebrafish and avian embryos (5, 6).
In the gastrulating chicken embryo, Raldh2 is first expressed by
mesodermal cells posterior to Hensen’s node, coinciding with a
critical period for anterior–posterior specification of cardiac
precursor cells (7). Fate mapping in chicks has shown that
Raldh2-expressing cells in the lateral mesoderm reside in the
proximity of sinoatrial precursors, allowing the diffusion of RA
into the cardiac field. Treatment with RA receptor antagonists
alters the cardiac fate map and leads to the abnormal presence
of ventricular precursors in the posterior cardiac field (7, 8).
Further supporting the idea that endogenous RA acts as a
regionally restricted signal imparting a sinoatrial fate to cardiac
precursor cells, both dietary vitamin A-deficient quail embryos
and Raldh2/ knockout mice display abnormal hearts, with a
highly hypoplastic inflow tract region and reduced Tbx5 and
Gata4 expression (4, 6).
Recent findings have changed our view of the origin of cardiac
progenitor cells in the mouse embryo. Indeed, several studies
have demonstrated that myocytes of the early heart tube derive
from two distinct progenitor populations (reviewed in ref. 9).
The heart tube is derived from cells of the first heart field (FHF),
which begins differentiation at an early stage and mainly con-
tributes to the left ventricle, and in part to the right ventricle and
atria. The second heart field (SHF) is a population of undiffer-
entiated multipotent cardiac precursor cells originating from the
pharyngeal mesoderm, which first lie medial to the FHF (9).
When the FHF differentiates as myocardium, the SHF is left in
the forming coelomic or pericardial cavity and lies ventral to the
foregut. It is from this position that SHF cells proliferate and are
progressively added to the poles of the heart tube (10, 11). The
SHF provides the precursor cells of the outflow tract (OFT) and
also participates in the formation of the right ventricle and atria
(10, 12). Growing evidence suggests the primary site of action of
RA may not be in the FHF but in the SHF. Both the Raldh2/
mutants rescued from early lethality by RA supplementation
(13) and a hypomorphic Raldh2 mutant (14) exhibit abnormal-
ities of the OFT and large vessels, reminiscent of the human
DiGeorge syndrome and similar to the phenotypes of murine
gene knockouts affecting the SHF, including an Fgf8 hypomor-
phic and Tbx1- and Foxh1-null mutations (reviewed in refs. 9 and
15). In later-stage RA-deficiency mutants, OFT defects are
accompanied by a profound disorganization of the posterior
pharyngeal region and reduced endodermal and mesodermal
expression of Fgf8, Hoxa1, and Hoxb1 (13, 14).
Here, we used several approaches to examine the contribution
of the SHF to pharyngeal mesoderm, atria, and OFT in RA-
deficient mouse embryos. By using the Mlc1v-nlacZ-24 reporter
line, in which a lacZ transgene has been inserted upstream of the
Fgf10 gene (16), we show that the anterior part of the SHF is
disorganized and posteriorly expanded in Raldh2/ mutants,
beginning at the four- to five-somite (forming heart tube) stage.
The endogenous patterns of Tbx1 and Fgf8 expression confirm
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this caudal expansion also seen with Islet-1 (Isl1), which marks
the whole SHF. Explant studies indicated that the differentiation
of cardiac progenitor cells located in the SHF is compromised
under Raldh2 deficiency, likely because of alterations in growth
factor signaling. In mutant embryos, the OFT, which derives
from the SHF, is absent and there is a severe disorganization of
the inflow tract. By using additional lacZ reporter transgenic
lines, we show that the RA-deficient heart tube is mainly formed
of myocardial cells with a right and left ventricular identity,
suggesting that the FHF contribution is not altered. Altogether,
these results document a role of RA in regulating SHF dynamics.
In the zebrafish embryo, RA deficiency leads to an enlarge-
ment of the early domains of Nkx2.5 expression, suggesting that
RA restricts the allocation of cardiac progenitors in the forming
cardiac field (5). Here, we provide evidence that the regulation
of Nkx2.5 by RA signaling may be direct, because we found that
the upstream regulatory region of the murine Nkx2.5 gene
contains five evolutionarily conserved RA-response elements of
the direct-repeat 5 (DR5) type, which may control late aspects
of Nkx2.5 regulation in SHF-derived OFT cells. To further
examine Raldh2-Nkx2.5 cross-regulation, we generated double
mutant mice and found that Nkx2.5 haploinsufficiency partly
rescues the posterior–anterior gradient of Tbx5 expression in the
heart tube of Raldh2/ mutants.
Results
To assess retinoid activity in the WT cardiac field, we used mice
harboring the RARE-hsp68-lacZ transgene, a sensitive reporter
for endogenous RA activity (17). This transgene has been shown
to be expressed in the posterior region of the early heart (8), and
we confirmed that expression was localized to two dorsal–medial
streams of the forming heart tube (Fig. 1A, arrowheads), a
domain absent in Raldh2/ mutants (data not shown). At the
five-somite stage, Raldh2 and Tbx5 expression domains con-
verged to overlap in the most posterior cardiac precursors in the
splanchnic mesoderm (Fig. 1 B and C). Similar domains of the
RA-responsive Hoxa1 homeobox gene (18) were present adja-
cent to the cardiac field in WT embryos at the five- to eight-
somite stages (Fig. 1D,E, andG), but these domains were absent
in Raldh2/ embryos (Fig. 1 F and H).
We crossed Raldh2/ mice with the Mlc1v-nlacZ-24 line, in
which a transgene integration into the Fgf10 locus leads to
transgene expression in the cardiac progenitors located in the
anterior heart field and, because of perduration of -galactosi-
dase (-gal), activity allows for marking the corresponding
myocardial derivatives (16). Although the early expression of this
reporter transgene did not show a major difference betweenWT
and Raldh2/ mutants at the one- to two-somite stages (Fig. 2
A and B), from the five-somite stage, its expression was clearly
altered in mutants. First, the labeled cells were dramatically
expanded toward posterior regions (compare Fig. 2 C and D,
arrowheads), an alteration that was accentuated at the seven-
somite stage (Fig. 2 E–J). Thus, in Raldh2/mutants the X-gal
staining was present in the lateral mesoderm well beyond the
level of the developing heart tube (compare Fig. 2 I with J,
arrowheads). Second, the closure of the dorsal mesocardium was
defective, because the midline gap in X-gal staining became
progressively wider in the Raldh2/ mutants (Fig. 2 D, F, and
J, brackets). To examine the activation of the Mlc1v-nlacZ-24
transgene in the lateral mesoderm lying posterior to the heart
tube, explants from this region were dissected at the zero- to
two-somite stage (a stage at which the transgene is not activated
posteriorly in Raldh2/ embryos; Fig. 2 A and B) and cultured
for 36 h. Explants from Raldh2/ mutants were X-gal-positive
after the in vitro culture (data not shown), indicating that the
expanded Mlc1v-nlacZ-24 pattern observed in whole embryos
does not result from an abnormal migration of anterior cells. At
later stages [embryonic day (E)9.0], X-gal activity in Mlc1v-
nlacZ-24;Raldh2/ mutants was spatially reduced compared
with control embryos (Fig. 2 K and L). The staining adjacent to
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Fig. 1. Retinoid signaling in theearlymouseheart. (A–D) Ventral viewsofWTembryos at thefive- to six-somite stage (5–6s). (A–D) Cryosections of theembryos
shown inA–D, with dotted lines indicating planes of sections. (A andA)WTRARE-hsp68-lacZ transgenic embryo at six-somite stage exhibits a domain of retinoid
activity in the splanchnic mesoderm (spm) adjacent to the forming heart tube (A, arrowheads). (B and B) Whole-mount ISH of Tbx5 in a five-somite-stage WT
embryo shows robust expression in the posterior most heart portion. (C and C) Double ISH of Tbx5 and Raldh2 in a five-somite-stage WT embryo reveals
complementary, although partly overlapping, expression domains in the splanchnic mesoderm. (D and D) Double ISH of Tbx5 and Hoxa1 in a five-somite-stage
WT embryo shows adjacent expression domains in splanchnic mesoderm.Whole-mount ISH ofHoxa1 inWT (E andG) and Raldh2/ (F andH) embryos indicates
thatRA is required to induceHoxa1expressionadjacent to the cardiacfield (Eand F) andcaudalpharyngealfield (GandH). Thearrowheads (E) indicateexpression
nearest to the cardiac field. ba, first branchial arch; fg, foregut; h, forming heart tube; lv, left ventricle; sm, somatic mesoderm; spm, splanchnic mesoderm.
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the WT second and third pharyngeal arches (Fig. 2K, arrowheads)
was absent in mutants, although expression was detected in the
anterior portion of the ‘‘unlooped’’ heart tube (Fig. 2 K and L).
We examined expression of other anterior markers of the SHF
such as Fgf8 and Tbx1. Fgf8 expression was more intense and
caudally expanded in Raldh2/ mutants, from the three- to
four-somite stage onward (Fig. 3 A–D). As for the Mlc1v-
nlacZ-24 transgene, Fgf8 expression was detected in the poste-
rior lateral mesoderm of the Raldh2/ mutant embryos at the
eight-somite stage (Fig. 3C andD; the greater expansion of the
Mlc1v-nlacZ-24 transgene may be attributable to -gal stability).
The T-box gene Tbx1, frequently deleted in human 22q11
deletion DiGeorge syndrome (reviewed in ref. 15), appears to be
genetically upstream of Fgf8 (19–22). WT embryos exhibited
pronounced Tbx1 expression in the SHF region caudal–medial to
Mlc1v-nlacZ-24 reporter staining (Fig. 3E andE), whereas Tbx1
expression appeared more intense and expanded in range in
Raldh2/ mutants starting at the three- to four-somite stage
(Fig. 3 F and F and data not shown). We also examined
expression of a pan-SHF progenitor cell marker, Isl1 (10).
Isl1-expressing cells in the splanchnic mesoderm give rise to
cardiomyocytes of the OFT, the right ventricle, atria, and inflow
region of the heart (10). Isl1 is also expressed in ventral and
lateral foregut endoderm (see Fig. 3G). Caudal expansion of
Isl1 expression was observed in Raldh2/mutants (Fig. 3G and
H), but the labeled cells did not extend into the heart tube where
cardiomyocytes are present (Fig. 3G andH). Altogether, these
observations suggest that endogenous RA may control the
antero-posterior location of cardiac progenitors of the SHF
within the splanchnic mesoderm.
Excess RA levels can often affect the same RA-regulated
signaling pathways as RA deficiency but in an opposite manner.
This was found to be the case when a single dose of RA was
administered to WT mice at late gastrulation (E7.5). These
treatments resulted in marked reductions of endogenous Fgf8
and Isl1 transcripts and of Mlc1v-nlacZ-24 reporter transgene
staining [supporting information (SI) Fig. 6].
We then examined Raldh2/ mutants for endogenous ex-
pression of Bmp2, -4, -6 and -7, which encode TGF family
members influencing myocardial differentiation (reviewed in
ref. 23). We found Bmp6, Bmp7 (SI Fig. 7 A–D), and Bmp2 (see
Fig. 5 F and H) levels to be reduced in the inflow region of the
mutants. Interestingly, at later stages (E9.0), Tgf2 expression
was markedly increased at the venous pole (septum transversum)
of the Raldh2/ unlooped heart (SI Fig. 7 E and F). A similar
hyperactivation of TGF signaling is observed in foregut tissues
of Raldh2/mutants at E8.5 and has been implicated in the lack
of lung induction (24).
The reductions in levels of Mlc1v-nlacZ-24 transgene expres-
sion (an Fgf10 enhancer trap) in the pharyngeal mesoderm of
Raldh2/ mutants at E9 (Fig. 2 K and L) suggest that FGF
signaling may be affected in the SHF. To further investigate this
pathway, we performed immunolocalization of p-ERK1/2, ef-
fectors of MAP signaling whose phosphorylation correlates with
FGF activity in the cardiac region (25). p-ERK1/2 levels were
found to be lower in the SHF at the 10-somite stage in Raldh2/
embryos (SI Fig. 7 G and H). Consistent with the decrease of
p-ERK levels, the expression of other FGF downstream targets
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Fig. 2. Retinoid deficiency causes SHF defects. WT and Raldh2/ Mlc1V-
nlacZ-24 transgenic embryos were analyzed by X-gal staining (A–F, ventral
views; G, H, K, and L, right-side views; I–J, transverse sections). At the one- to
two-somite stage, transgene expression is unaltered in mutants (A and B). At
the five-somite (C and D) and seven-somite (E and F) stages, red arrowheads
point to the caudal limit of expression in the SHF, which is expanded in
Raldh2/ mutant embryos (D and F). Note the abnormally large gap in
midline staining in mutants (brackets). (G and H) Right-side views of embryos
shown in E and F. The arrows indicate planes of sections in I–J. (I and J)
Transverse sections reveal -gal cells in splanchnic epithelium (white arrow-
heads) adjacent to foregut endoderm, in somatic mesoderm (black arrow-
heads), and in heart tube myocardium. Note that dorsal mesocardium is not
closed in the Raldh2/ embryo (J, bracket). (I and J) Expansion of Mlc1v-
nlacZ-24 transgene expression is seen in posterior lateral mesoderm (arrow-
heads) of the Raldh2/mutant (J). (K and L) Right-side views of E9.0WT and
Raldh2/ embryos, showing details of the heart and adjacent pharyngeal
region. The arrowheads point to pharyngeal staining, which is almost unde-
tectable in the mutant. fl, forelimb; ht, heart tube; ot, OFT; rv, right ventricle.
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Fig. 3. Caudal expansion of the SHF in RA-deficient mutants. Whole-mount
ISH analysis of Fgf8 (A–D), Tbx1 combined with X-gal staining for Mlc1v-
nlacZ-24 (E–F) and Isl1 (G–H). The arrows or dotted lines in C–H indicate
planes of sections shown in C–H. (A–D) Brackets indicate endogenous Fgf8
expression in the anterior part of the SHF, which is expanded in Raldh2/
mutants (B and D). (D) A transverse section of the embryo shown in D reveals
Fgf8 expression in the lateral mesoderm. (E and F) Ventral of WT and
Raldh2/ embryos at the three- to four-somite stage showing a caudal
expansion of Mlc1v-nlacZ-24 transgene expression and Tbx1. (E–F) Trans-
verse sections further illustrate the caudal expansion ofMlc1v-nlacZ-24 trans-
gene activity and Tbx1 transcripts. (G and H) Right-side views of WT and
Raldh2/ embryos at the 10-somite stage showing an expansion of the
pan-SHF marker Isl1 under RA deficiency (H). (G and H) Transverse sections
show Isl1 expression in the splanchnic mesoderm (the SHF) and the ventral
foregut endodermof both embryos. Of note, there is no ectopic expression of
Isl1 transcripts in the myocardium of the mutant heart (compare G with H).
cm, cranial mesoderm; dm, dorsal mesocardium; lm, lateral mesoderm.
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(Sprouty1 and -2 and Mkp3; SI Fig. 7 I–J and data not shown)
was also reduced in the pharyngeal region and splanchnic
mesoderm of mutants.
To examine myocardial subdomains in the RA-deficient hearts,
we crossed Raldh2/ mutants with additional, region-specific
reporter transgenes. The y96-Myf5-nlacZ-16 transgene displays a
domain of expression in theWTOFTmyocardium beginning at the
12- to 14-somite stage (26), which was absent in Raldh2/mutants
(Fig. 4 A and B). The absence or reduction of OFT myocardium in
mutants was confirmed by theMlc3f-nlacZ-9 pattern (Fig. 4 C and
D). This transgene is known to be silenced inWTOFTmyocardium
(12) (Fig. 4C, bracket). In mutants, most if not all of the unlooped
heart tube contained Mlc3f-nlacZ-9-labeled cells (Fig. 4D). These
observations indicate that the deployment of SHF cells to the OFT
was highly compromised inRaldh2/mutant embryos. In contrast,
the activity of theMlc3f-nlacZ-2E transgene, normally expressed in
left but not right ventricular myocardium (Fig. 4 E andG), was well
detected in the Raldh2/ heart tube (compare Fig. 4 E andG with
F andH) (12). These results strongly suggest that FHF contribution
is not affected underRAdeficiency. To estimate themyocardial cell
numbers and the presence of differentiating cardiomyocytes in the
Raldh2/mutant hearts, we counted the number of -gal-positive
and -actinin-positive cells on serial sections of WT and Raldh2/
embryos from the Mlc3f-nlacZ-9 line (SI Fig. 8). At E9.5, we
estimated a deficiency of 30%, both in the overall number of
-gal-positive cells and of differentiating (-actinin-positive) car-
diomyocytes in Raldh2/ mutants, which may correspond to the
defects observed in the outflow and inflow regions.
To further explore the differentiation potential of Raldh2/
cardiomyocytes, explants of SHF isolated from three- to five-
somite stage WT and Raldh2/ embryos carrying the Mlc1v-
nlacZ-24 transgene were cultured for 48 h and X-gal-stained to
identify SHF cells and derivatives (12, 16). Under these estab-
lished culture conditions, WT SHF explants consistently under-
went cardiac differentiation, characterized by the presence of
beating cells and expression of myosin heavy chain (MF20), quite
similar to heart explants cultured from the same embryos (SI
Table 1; also see ref. 12). Raldh2/ mutant SHF explants,
however, never differentiated or formed beating cardiomyo-
cytes, in contrast to their heart, which was still beating under the
same culture conditions (SI Table 1). This suggested that the
Raldh2/ mutant SHF was impaired in its ability to contribute
to differentiated cardiomyocytes, potentially because of reduced
bone morphogenetic protein (BMP) signaling.
The intriguing finding that both Raldh2 deficiency and RA
receptor antagonism in zebrafish embryos resulted in the pro-
duction of excess myocardial progenitors, marked by up-
regulated Nkx2.5 expression during gastrulation (5), led us to
investigate potential mechanisms for cross-regulation between
the retinoid and Nkx2.5 transcriptional pathways. One avenue to
examine such interactions is to generate compound mutants.
Insertion of a Cre transgene in the Nkx2.5 locus (27) disrupts
expression of this gene, so that when mated to homozygosity, the
resulting embryos phenocopy previously reported Nkx2.5/
mutants (27–29). We crossed Nkx2.5-Cre mutants with
Raldh2/ mice and analyzed compound mutants at E8.5 for
Tbx5 expression as a marker for the posterior portion of the
heart, which is destined to become the sinus venosa and atria
(30). As expected, the domain of Tbx5 expression was reduced
in Raldh2/ embryos (compare Fig. 5 A with C), correlating
with an abnormal morphogenesis of the inflow region (4).
Interestingly, Nkx2.5 haploinsufficiency partially rescued Tbx5
expression in Raldh2/ embryos (Fig. 5D). Complete Nkx2.5
deficiency further expanded Tbx5 expression in Raldh2/;
Nkx2.5/ compound mutants (Fig. 5E). Prall et al. (31) have
demonstrated that Nkx2.5 deficiency up-regulates Bmp2 expres-
sion, which may result in increased myocardial differentiation.
We likewise observed expanded Bmp2 expression in our
Nkx2.5/ mutants (Fig. 5G). Although Bmp2 levels were re-
duced in Raldh2/mutants (Fig. 5H), we found that these levels
were progressively normalized upon removal of functional
Nkx2.5 alleles (Fig. 5 I and J). Additionally, SHF expression, as
assayed by Isl1 expression, appeared essentially unaltered in
Raldh2/ mutants under Nkx2.5 deficiency (data not shown).
By performing a VISTA-based promoter search for transcrip-
tional binding sites in evolutionary conserved regions, we un-
covered an upstream regulatory region of the Nkx2.5 gene
containing five conserved RA-response elements (RAREs) of
the DR5 type. A lacZ transgenic line was generated by using a
BAC fragment containing the region located from14.8 to7.5
kb upstream of the Nkx2.5 transcriptional start site, which
included the RAREs. This fragment was sufficient to drive lacZ
reporter expression in the FHF (SI Fig. 9 A–C), similar to
endogenous Nkx2.5 expression (28). Whereas the early domain
of endogenous Nkx2.5 (data not shown) and Nkx2.5 transgene
expression in the cardiac crescent was not altered in Raldh2/
mutants (SI Fig. 9D–F), endogenousNkx2.5was expanded in the
SHF of mutants at E8.5 (SI Fig. 9 G and H, arrowheads).
However, transgene expression was reduced in the OFT and the
right ventricle of RA-supplemented Raldh2/ embryos at E10.5
(SI Fig. 9 I and J). These observations suggest that Nkx2.5
regulation is not RA-dependent in the FHF and at early stages
in the SHF, although eventually it is affected when RA levels are
decreased at later stages of development.
Discussion
Originally RA was proposed to regulate the anterior–posterior
specification of cardiac progenitors within the FHF. Indeed, pos-
terior cells of the early FHF are encircled byRaldh2-expressing cells
in the lateral mesoderm. Blocking RA signaling in chick embryos
inhibited atrial differentiation and altered the cardiac fate map, so
that ventricular progenitors extended outside of their normal
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Fig. 4. Transgenic reporter lines reveal OFT defects and normal FHF contri-
bution inRaldh2/embryos. (AandB) Right-side viewsofX-gal stainedE9WT
and Raldh2/ embryos, showing absence of y96-Myf5-nlacZ-16 transgene
expression, a marker of the OFT (arrowheads), in the mutant. (C and D) In
Mlc3f-nlacZ-9 hearts at the 14-somite stage, X-gal staining distinguishes the
OFT lacking transgene activity (C, bracket) and the right ventricle. -Gal
activity is also detected in the left ventricle. The nonexpressing domain
(presumptive OFT) is absent under RA deficiency (D). The white lines indicate
planes of sections in C and D. (E and F) At the eight-somite stage, Mlc3f-
nlacZ-2E transgene expression marks the presumptive right atria and left
ventricle in bothWT (E) and Raldh2/mutants (F). (G andH) Ventral views of
X-gal stained Mlc3f-nlacZ-2E WT and Raldh2/ embryos at the 16-somite
stage showing the distinction between right (arrowheads) and left ventricles.
White lines indicate planes of sections in G and H. ra, right atria.
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domains (7). Keegan et al. (5) further have found that RA defi-
ciency results in an expansion of cardiac progenitors during gas-
trulation in zebrafish, via a direct fate transformation.
Our results, although partly consistent with previous findings,
now show that RA regulates SHF organization within the precise
time frame in which RA deficiency affects cardiac formation in
avian and mammalian models. We also observed an overlap
between the region of RA signaling and the caudal limit of SHF
marker gene expression, correlating with an anterior domain of
Hoxa1 expression in WT embryos, a domain that is absent in
Raldh2 mutants. Because restoring Hoxa1 expression in RA-
deficient amphioxus embryos can rescue patterning defects (32),
we postulate that the lack ofHoxa1 expression in the cardiac field
may result in cardiac perturbations found in Raldh2mutants (4).
We found that the earliest events of cardiac RA deficiency were
the caudal expansions of SHF gene expression, occurring at a
stage when cardiac defects become irreversible in an avian
vitamin A-deficiency model (33). We propose that these initial
molecular alterations in SHF expression are why RA-deficient
heart formation cannot be restored after this time. Additional
reductions in the right ventricle and absence of OFT because of
impaired SHF integration in the forming heart tube probably
contributes to abnormal cardiac looping also found in other SHF
mutants such as Isl1, Mef2c, and Nkx2.5 (10, 31, 34).
Some genetic cross-talk exists between Nkx2.5 and RA sig-
naling, because we show here that reducing Nkx2.5 gene dosage
can rescue aspects of theRaldh2/ cardiac phenotype, including
Tbx5 expression.Nkx2.5/mutants have an apparent expansion
of the FHF contribution to the left ventricle (31). Hence it may
have been expected that Nkx2.5 loss of function would have
worsened the Raldh2/ cardiac phenotype. More likely it is the
feedback repression that Nkx2.5 normally imposes on Bmp2/
Smad signaling (31), which when relieved may improve the RA
deficiency phenotype. Transplantation of WT foregut
endoderm, or exogenous supply of BMP2 and Gata4, can restore
heart morphology in vitamin A-deficient quail embryos (35, 36).
Although Bmp2 expression indeed appears up-regulated in
Nkx2.5;Raldh2 compound mutants, further genetic strategies are
required to clarify the precise manner by which these two
signaling pathways interact.
The importance of Fgf8 in SHF signaling has been noted (19,
20, 22, 37, 38). Our study indicates that a primary mechanism by
which RA regulates SHF dynamics may be by modulating FGF
signaling. We show that endogenous RA is required to prevent
Fgf expression in the posterior lateral mesoderm (including in
the posterior region of the SHF). Not only did RA deficiency
lead to expanded Fgf8 and Fgf10 (Mlc1v-nlacZ-24-enhancer
trap) expression, this expansion occurred at approximately the
five-somite stage, when cardiac defects become irreversible in
the quail vitamin A-deficiency model (33). Conversely, we saw
that excess exogenous RA reduces SHF Fgf8 levels, similar to
what has been observed when endogenous RA is increased by
blocking the activity of its metabolizing CYP26 enzymes (39).
One puzzling finding in Raldh2 mutants was that despite the
expansion of the SHF at early stages of development, eventually
the contribution of SHF cells to the heart tube was compromised.
Explant studies demonstrate that mutant SHF cells are impaired
in their ability to differentiate and to form beating cardiomyo-
cytes. Several explanations may account for these findings.
Reduction in BMP signaling, found in Raldh2mutants, may lead
to the absence of bona fide cardiac induction. Accordingly, FGFs
can only elicit cardiomyogenic effects in regions where BMP
signaling is also present (40). Alternately, the expanded early
FGF8 signaling may hinder the capacity of the prospective
myocardial SHF cells to develop and correctly function, similar
to what is observed at slightly later stages when excess FGF8
resulting from cardiac neural crest ablation disrupts myocardial
function (37, 41). Moreover, altering RA-Fgf8 regulatory inter-
actions may produce adverse consequences. In prostate cancer
cells, RA activation of the Fgf8 promoter produces a switch of
splice isoforms, so that a less mitotically active isoform (Fgf8a)
accumulates (42). Because both canonical and novel RA-
response elements in the Fgf8 promoter can be activated by
unliganded RAR in COS cells (43), an absence of RA may
produce an accumulation of the more proliferative Fgf8b prod-
uct. Hypothetically, the absence of RAR ligand in Raldh2/
mutants may favor Fgf8b expression, hindering early SHF pro-
genitor differentiation by its increased mitotic activity.
In conclusion, mutual inhibition between FGF and RA path-
ways may control cardiac stem cell dynamics and cardiomyocyte
differentiation, similar to what has been described during caudal
neuronal stem cell production and neural tube differentiation
(reviewed in ref. 44). In this tail bud of chick embryos at early
somite stages, Fgf8 expression marks the caudal source of
neuronal stem cells, which under RA deficiency is expanded.
The ability of neural progenitors to differentiate, however, is
impaired when RAR signaling is blocked (44). Similarly we
observed that cardiac stem cell populations, marked by Isl1
expression (45), were expanded under RA deficiency, whereas
SHF cardiomyocyte differentiation was impaired. Further un-
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Fig. 5. Genetic interaction between the retinoid and Nkx2.5 pathways. Sinoatrial Tbx5 expression (A, WT embryo) is reduced in Raldh2/ mutants (C).
Inactivation of oneNkx2.5 allele results in an expanded Tbx5 domain in Raldh2/mutants (D), similar toNkx2.5/mutants (B) andNkx2.5/;Raldh2/ double
mutants (E). Bmp2 expression (F, WT embryo) is increased in Nkx2.5/mutants (G) and moderately reduced in Raldh2/mutants (H). Inactivation of one (I) or
both (J) Nkx2.5 allele(s) progressively increases Bmp2 levels in Raldh2/ mutants. All embryos are at the 8- to 10-somite stage. Profile views are shown.
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derstanding of howRA regulates cardiac progenitors and growth
factor pathways in the early embryo may engender novel ideas
about how to regulate cardiac stem cell dynamics in humans.
Materials and Methods
In Situ Hybridization and Immunohistochemistry.Raldh2-nullmutantmice have
been described (3) as well as the maternal RA supplementation procedure
(46). The lacZ reporter transgenic lines have been described (12, 26). Whole-
mount in situ hybridization (ISH) was performed as described (12) by using
Intavis InSituPro robots. Double whole-mount ISH with digoxigenin- and
FITC-labeled riboprobes were performed according to the Stern laboratory
protocol. Transgenic expression was monitored by X-gal assays as described
(12). Whole-mount immunolabelingwith anti p-ERK1/2 antibody (Cell Signal-
ing) was performed according to the Rossant laboratory protocol.
Retinoic Acid Treatment of Embryos. All-trans-RA (Sigma) was dissolved in
DMSO and diluted at 20 mg/ml. At E7.5, the mice were given a single i.p.
injection of the RA solution (65 mg/kg) or control DMSO.
Embryonic Explant Cultures. The region posterior to the FHF up to the allantois
was dissected from zero- to two-somite stage embryos collected and trans-
ferred to culture medium in collagen (1%) coated multiwell dishes. For older
embryos, the heart tube alone or pharyngeal mesoderm (including pharyn-
geal endoderm) was dissected and transferred to culture medium. Explants
were cultured as described (12) for 36 to 48 h. Fluorescent immunohistochem-
istry was performed by using the anti-myosin heavy chain antibody MF20
(Developmental Studies Hybridoma Bank, University of Iowa, Iowa City, IA) at
a 1/100 dilution. Explant experiments were repeated several times for each
transgenic line and time point (SI Table 1).
Analysis of Myocardial Cell Numbers. Cell counting was assessed on 14-m
sections by using rabbit polyclonal anti--Gal (1:500; Cappel) andmonoclonal
anti-sarcomeric -actinin (clone EA-53, 1:500; Sigma) followed by DAPI stain-
ing. The number of myocardial cells (DAPI nuclei in -actinin cells) and
-gal cells (combined DAPI and -Gal nuclei) were recorded on all serial
sectionsofMlc3f-nlacZ-9 transgenic embryos (n3 foreachgenotype) at E9.5.
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